Amarantus BioScience Holdings, Inc. Stock
Equities
AMBS
US02300U2050
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | -80.00% |
Financials (USD)
Sales 2014 | - | Sales 2015 | - | Capitalization | 8.57M |
---|---|---|---|---|---|
Net income 2014 | -27M | Net income 2015 | -25M | EV / Sales 2014 | - |
Net cash position 2014 | 89K | Net Debt 2015 | 2.96M | EV / Sales 2015 | - |
P/E ratio 2014 |
-2.06
x | P/E ratio 2015 |
-0.15
x | Employees | 12 |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
3 months | -66.67% | ||
6 months | -85.71% | ||
Current year | -80.00% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 08-01-13 | |
Founder | 41 | 08-01-13 | |
Donald Huffman
CEO | Chief Executive Officer | 77 | 14-07-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Huffman
CEO | Chief Executive Officer | 77 | 14-07-21 |
Founder | 79 | 08-01-13 | |
Founder | 41 | 08-01-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.0001 | 0.00% | 200 |
Delayed Quote OTC Markets, May 08, 2024 at 12:12 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-80.00% | 63.04K | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- AMBS Stock